114 related articles for article (PubMed ID: 6383923)
1. A beta-cell glycoprotein of Mr 40 000 is the major rat islet cell immunogen following xenogenic immunisation.
Baekkeskov S; Lernmark A
Diabetologia; 1984 Jul; 27 Suppl():70-3. PubMed ID: 6383923
[TBL] [Abstract][Full Text] [Related]
2. Specific pancreatic beta-cell surface antigens recognized by a xenogenic antiserum.
Dyrberg T; Baekkeskov S; Lernmark A
J Cell Biol; 1982 Aug; 94(2):472-7. PubMed ID: 7050130
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody-mediated cytotoxicity against rat beta cells detected in vitro does not cause beta-cell destruction in vivo.
Ziegler B; Lucke S; Köhler E; Hehmke B; Schlosser M; Witt S; Besch W; Ziegler M
Diabetologia; 1992 Jul; 35(7):608-13. PubMed ID: 1644238
[TBL] [Abstract][Full Text] [Related]
4. Effect of islet cell surface antibodies on neonatal rat pancreatic islet cells or isolated islets of Langerhans in vitro.
Schröder D; Hehmke B; Kohnert KD; Fiebach H; Jenssen HL; Besch W
Biomed Biochim Acta; 1985; 44(1):107-15. PubMed ID: 3888202
[TBL] [Abstract][Full Text] [Related]
5. Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes.
Lander T; Nerl C; Held M; Standl E; Mehnert H
Diabetes; 1989 Dec; 38(12):1557-66. PubMed ID: 2555242
[TBL] [Abstract][Full Text] [Related]
6. Specific monoclonal antibodies against the surface of rat islet beta cells.
Konidaris C; Simonson W; Michelsen B; Papadopoulos GK
Cell Biol Int; 2002; 26(9):817-28. PubMed ID: 12377213
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of islet cell autoantibodies in terms of insulin release from rat islets and insulinoma cells.
Ejiri K; Taniguchi H; Morimoto Y; Yamashiro Y; Baba S; Srikanta S; Eisenbarth GS
Diabetes Res Clin Pract; 1990 Apr; 9(1):1-5. PubMed ID: 2161728
[TBL] [Abstract][Full Text] [Related]
8. Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement.
Kanatsuna T; Lernmark A; Rubenstein AH; Steiner DF
Diabetes; 1981 Mar; 30(3):231-4. PubMed ID: 7009272
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of monoclonal islet cell surface antibodies reacting with RINm5AH insulinoma cells.
Vissing H
Biomed Biochim Acta; 1985; 44(1):123-7. PubMed ID: 3888204
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic islet cell surface glycoproteins containing Gal beta 1-4GlcNAc-R identified by a cytotoxic monoclonal autoantibody.
Uchigata Y; Spitalnik SL; Tachiwaki O; Salata KF; Notkins AL
J Exp Med; 1987 Jan; 165(1):124-39. PubMed ID: 2432147
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR-restricted T cell lines from newly diagnosed type 1 diabetic patients specific for insulinoma and normal islet beta cell proteins: lack of reactivity to glutamic acid decarboxylase.
Huang GC; Tremble J; Bailyes E; Arden SD; Kaye T; McGregor AM; Banga JP
Clin Exp Immunol; 1995 Oct; 102(1):152-8. PubMed ID: 7554382
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects of islet cell surface antibodies.
Hehmke B; Kohnert KD; Dietz H; Zühlke H
Acta Biol Med Ger; 1982; 41(12):1117-22. PubMed ID: 6765153
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells.
Cavallo MG; Dotta F; Monetini L; Dionisi S; Previti M; Valente L; Toto A; Di Mario U; Pozzilli P
J Endocrinol; 1996 Jul; 150(1):113-20. PubMed ID: 8708552
[TBL] [Abstract][Full Text] [Related]
14. Effects of islet cell surface antibodies on isolated neonatal rat islets of Langerhans in vitro.
Schröder D; Kohnert KD; Hehmke B; Besch W
Allerg Immunol (Leipz); 1986; 32(2):111-21. PubMed ID: 2942021
[TBL] [Abstract][Full Text] [Related]
15. Serum reactivity against RINm5F purified membrane antigens (ICMA) in newly diagnosed diabetic subjects.
Giordano C; Sapienza N; Mattina A; Pugliese A; Galluzzo A
Diabetes Res; 1990 Nov; 15(3):113-6. PubMed ID: 2132203
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to a human islet cell surface glycoprotein: 4F2 and LC7-2.
Srikanta S; Telen M; Posillico JT; Dolinar R; Krisch K; Haynes BF; Eisenbarth GS
Endocrinology; 1987 Jun; 120(6):2240-4. PubMed ID: 2436897
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies against pancreatic islet-cell-surface antigens selected by flow cytofluorometry.
Vissing H; Papadopoulos G; Lernmark A
Scand J Immunol; 1986 Apr; 23(4):425-33. PubMed ID: 3518043
[TBL] [Abstract][Full Text] [Related]
18. Rodent islet cell antigens recognized by antibodies in sera from diabetic patients.
Baekkeskov S; Lernmark A
Acta Biol Med Ger; 1982; 41(12):1111-5. PubMed ID: 6765152
[TBL] [Abstract][Full Text] [Related]
19. Production of monoclonal antibodies to islet cell surface antigens using hybridization of spleen lymphocytes from non-obese diabetic mice.
Yokono K; Shii K; Hari J; Yaso S; Imamura Y; Ejiri K; Ishihara K; Fujii S; Kazumi T; Taniguchi H
Diabetologia; 1984 May; 26(5):379-85. PubMed ID: 6376247
[TBL] [Abstract][Full Text] [Related]
20. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro.
Kohnert KD; Hehmke B; Fält K; Ziegler M
Biomed Biochim Acta; 1984; 43(5):663-73. PubMed ID: 6206850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
